Cicor Technologies S.A. Stock
Price
Target price
€144.00
€144.00
0.140%
0.2
0.140%
-
09:30 / Tradegate
WKN: 913744 / Name: Cicor Tech / Stock / Semiconductors & Semiconductor Equipment / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Cicor Technologies S.A. Stock
The Cicor Technologies S.A. stock is trending slightly upwards today, with an increase of €0.20 (0.140%) compared to yesterday's price.
Pros and Cons of Cicor Technologies S.A. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cicor Technologies S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cicor Technologies S.A. | 0.140% | 5.117% | 16.343% | -29.510% | 6.125% | - | - |
| Nova Measuring Instruments | 1.050% | 6.604% | -12.276% | 66.329% | 27.414% | 233.887% | 346.420% |
| Hana Microelectronics PCL | 20.390% | 10.753% | 4.040% | 88.991% | 151.220% | -20.155% | -43.407% |
| Hana Microelectronics -NVDR- | 5.760% | 8.602% | 2.538% | 85.321% | 146.341% | -23.485% | -45.699% |
News
Cicor signed a CHF 425 million unsecured term and revolving credit facilities agreement to support its next phase of growth
Cicor signed a CHF 425 million unsecured term and revolving credit facilities agreement to support its next phase of growth
Cicor and Singapore based EDMI agree to enter into a strategic outsourcing agreement
Cicor and Singapore based EDMI agree to enter into a strategic outsourcing agreement
Cicor reports strong H1 order intake with a book-to-bill ratio of 1.2 and returns to organic growth in Q2
Cicor reports strong H1 order intake with a book-to-bill ratio of 1.2 and returns to organic growth in Q2


